Exciting New Research Results Reported at the Recent European Society of ... - EON: Enhanced Online News (press release)
EON: Enhanced Online News (press release)Exciting New Research Results Reported at the Recent European Society of .
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market ... - Sacramento Bee
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market .
Loopholes in pharma pricing policy - Hindu Business Line
Hindu Business LineLoopholes in pharma pricing policyHindu Business LineSimilarly in the class of angiotensin II receptor antagonists (also used in high blood pressure), we have losartan potassium in the NLEM 2011 list but not candesartan, irbesartan, telmisartan, valsartan and olmesartan.